liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Validation of a Preclinical Spinal Safety Model Effects of Intrathecal Morphine in the Neonatal Rat
Linköping University, Department of Medical and Health Sciences. Linköping University, Faculty of Health Sciences.
University of California.
Oregon Health and Science University.
Show others and affiliations
2010 (English)In: Anesthesiology, ISSN 0003-3022, E-ISSN 1528-1175, Vol. 113, no 1, 183-199 p.Article in journal (Refereed) Published
Abstract [en]

Background: Preclinical studies demonstrate increased neuro-apoptosis after general anesthesia in early life. Neuraxial techniques may minimize potential risks, but there has been no systematic evaluation of spinal analgesic safety in developmental models. We aimed to validate a preclinical model for evaluating dose-dependent efficacy, spinal cord toxicity, and long-term function after intrathecal morphine in the neonatal rat. Methods: Lumbar intrathecal injections were performed in anesthetized rats aged postnatal day (P) 3, 10, and 21. The relationship between injectate volume and segmental spread was assessed postmortem and by in vivo imaging. To determine the antinociceptive dose, mechanical withdrawal thresholds were measured at baseline and 30 min after intrathecal morphine. To evaluate toxicity, doses up to the maximum tolerated were administered, and spinal cord histopathology, apoptosis, and glial response were evaluated 1 and 7 days after P3 or P21 injection. Sensory thresholds and gait analysis were evaluated at P35. Results: Intrathecal injection can be reliably performed at all postnatal ages and injectate volume influences segmental spread. Intrathecal morphine produced spinally mediated analgesia at all ages with lower dose requirements in younger pups. High-dose intrathecal morphine did not produce signs of spinal cord toxicity or alter long-term function. Conclusions: The therapeutic ratio for intrathecal morphine (toxic dose/antinociceptive dose) was at least 300 at P3 and at least 20 at P21 (latter doses limited by side effects). These data provide relative efficacy and safety for comparison with other analgesic preparations and contribute supporting evidence for the validity of this preclinical neonatal safety model.

Place, publisher, year, edition, pages
Lippincott Williams and Wilkins; 1999 , 2010. Vol. 113, no 1, 183-199 p.
National Category
Engineering and Technology
URN: urn:nbn:se:liu:diva-58280DOI: 10.1097/ALN.0b013e3181dcd6ecISI: 000279244800021OAI: diva2:337926
Available from: 2010-08-10 Created: 2010-08-09 Last updated: 2014-01-14

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Westin, David
By organisation
Department of Medical and Health SciencesFaculty of Health Sciences
In the same journal
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 33 hits
ReferencesLink to record
Permanent link

Direct link